Dopamine D2 receptors in signal transduction and behavior

Critical Reviews in Neurobiology

Volumn 11, Issue 2-3, 1997, Pages 121-142

  Picetti, Roberto ^a   Saiardi, Adolfo ^a   Samad, Tarek Abdel ^a   Bozzi, Yuri ^a   Baik, Ja Hyun ^b   Borrelli, Emiliana ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b Yonsei University   (South Korea)

Author keywords

Basal ganglia; Knockout; Parkinson's disease; Pharmacology; Seven transmembrane domain G protein coupled receptors; Signal transduction

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PEPTIDE HORMONE; RECEPTOR SUBUNIT;

AMINO ACID SEQUENCE; BASAL GANGLION; BEHAVIOR; CENTRAL NERVOUS SYSTEM; HORMONE SYNTHESIS; HYPOPHYSIS; LOCOMOTION; PARKINSON DISEASE; PHYSIOLOGY; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR GENE; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030684728     PISSN: 08920915     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevNeurobiol.v11.i2-3.20     Document Type: Review

References (130)

1. Gerfen, C. R., The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia, Annu. Rev. Neurosci, 15, 285, 1992.
2. Carlsson, A., The occurrence, distribution and physiological role of catecholamines in the nervous system, Pharmacol. Rev., 11, 490, 1959.
3. Doppler, W., Regulation of gene expression by prolactin, Rev. Physiol. Biochem. Pharmacol., 124, 93, 1994.
4. Gingrich, J. A. and Caron, M. G., Recent advances in the molecular biology of dopamine receptors, Annu. Rev. Neurosci., 16, 299, 1993.
5. Sokoloff, P. and Schwartz, J. C., Novel dopamine receptors half a decade later, Trends Pharmacol. Sci., 16, 270, 1995.
6. Bunzow, J. R., Van Tol, H. H., Grandy, D. K., Albert, P., Salon, J., Christie, M., Machida, C. A., Neve, K. A., and Civelli, O., Cloning and expression of a rat D2 dopamine receptor cDNA [see comments], Nature, 336, 783, 1988.
7. Giros, B., Sokoloff, P., Martres, M. P., Riou, J. F., Emorine, L. J., and Schwartz, J. C., Alternative splicing directs thé expression of two D2 dopamine receptor isoforms, Nature, 342, 923, 1989.
8. Montmayeur, J. P., Bausero, P., Amlaiky, N., Maroteaux, L., Hen, R., and Borrelli, E., Differential expression of the mouse D2 dopamine receptor isoforms, FEBS Lett., 278, 239, 1991.
9. Chio, C. L., Hess, G. F., Graham, R. S., and Huff, R. M., A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus, Nature, 343, 266, 1990.
10. Dal Toso, R., Sommer, B., Ewert, M., Herb, A., Pritchett, D. B., Bach, A., Shivers, B. D., and Seeburg, P. H., The dopamine D2 receptor: two molecular forms generated by alternative splicing, EMBO J., 8, 4025, 1989.
11. Martens, G. J., Molhuizen, H. O., Groneveld, D., and Roubos, E. W., Cloning and sequence analysis of brain cDNA encoding a Xenopus D2 dopamine receptor, FEBS Lett., 281, 85, 1991.
12. Kukstas, L. A., Domec, C., Bascles, L., Bonnet, J., Verrier, D., Israel, J. M., and Vincent, J. D., Different expression of the two dopaminergic D2 receptors, D2415 and D2444, in two types of lactotroph each characteris̀ed by their response to dopamine, and modification of expression by sex steroids, Endocrinology, 129, 1101, 1991.
13. Minowa, T., Minowa, M. T., and Mouradian, M. M., Analysis of the promoter region of the rat D2 dopamine receptor gene, Biochemistry, 31, 8389, 1992.
14. Valdenaire, O., Vernier, P., Maus, M., Dumas Milne Edwards, J. B., and Mallet, J., Transcription of the rat dopamine-D2-receptor gene from two promoters, Eur. J. Biochem., 220, 577, 1994.
15. Minowa, M. T., Minowa, T., and Mouradian, M. M., Activator region analysis of the human D1A dopamine receptor gene, J. Biol. Chem., 268, 23544, 1993.
16. Minowa, M. T., Minowa, T., and Mouradian, M. M., Negative modulator of the rat D2 dopamine receptor gene, J. Biol. Chem., 269, 11656, 1994.
17. Jackson, D. M. and Westlind-Danielsson, A., Dopamine receptors: molecular biology, biochemistry and behavioural aspects, Pharmacol. Ther., 64, 291, 1994.
18. Stormann, T.M., Gdula, D.C., Weiner, D.M., and Brann, M. R., Molecular cloning and expression of a dopamine D2 receptor from human retina, Mol. Pharmacol., 37, 1, 1990.
19. Dearry, A., Falardeau, P., Shores, C., and Caron, M. G., D2 dopamine receptors in the human retina: cloning of cDNA and localization of mRNA, Cell Mol. Neurobiol, 11, 437, 1991.
20. Aumenta, F., Density and distribution of dopamine receptors in the cardiovascular system and in the kidney, J. Auton. Pharmacol., 10 (Suppl. 1), 11, 1990.
21. Jose, P. A., Raymond, J. R., Bates, M. D., Aperia, A., Felder, R. A., and Carey, R. M., The renal dopamine receptors, J. Am. Soc. Nephrol., 2, 1265, 1992.
22. Escaf, S., Cavallotti, C., Ricci, A., Vega, J. A., and Amenta, F., Dopamine D1 and D2 receptors in the human ureter and urinery bladder: a radioligand binding and autoradiographic study, Br. J. Urol., 73, 473, 1994.
23. Amenta, F. and Ricci, A., Dopamine receptors in the cardiovascular system, Funct. Neurol., 6, 219, 1991.
24. Autelitano, D. J., Snyder, L., Sealfon, S. C., and Roberts, J. L., Dopamine D2 receptor messenger RNA is differentially regulated by dopaminergic agents in the rat anterior and neurointermediate pituitary, Mol. Cell Endocrinol., 67, 101, 1989.
25. Seeman P., Receptor Table. Vol. 2: Drug Dissociation Constants for Neuroreceptors and Transporters, Printed by SZ Research, Toronto, 1993.
26. Seeman, P. and Van Tol, H. H., Dopamine receptor pharmacology, Trends Pharmacol. Sci., 15, 264, 1994.
27. Levesque, D., Diaz, J., Pilon, C., Martres, M. P., Giros, B., Souil, E., Schott, D., Morgat, J. L., Schwartz, J. C., and Sokoloff, P., Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin, Proc. Natl. Acad. Sci. U.S.A., 89, 8155, 1992.
28. Le Moine, C., Normand, E., and Bloch, B., Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene, Proc. Natl. Acad. Sci. U.S.A., 88, 4205, 1991.
29. Surmeier, D. J., Reiner, A., Levine, M. S., and Ariano, M. A., Are neostriatal dopamine receptors co-localized? Trends Neurosci., 16, 299, 1993.
30. Civelli, O., Bunzow, J. R., Grandy, D. K., Zhou, Q. Y., and Van Tol, H. H., Molecular biology of the dopamine receptors, Eur. J. Pharmacol., 207, 277, 1991.
31. Chesselet, M. F., Presynaptic regulation of dopamine release. Implications for the functional organization of the basal ganglia, Ann. NY Acad. Sci., 604, 17, 1990.
32. Bannon, M. J., Michaud, R. L., and Roth, R. H., Mesocortical dopamine neurons. Lack of autoreceptor modulating dopamine synthesis, Mol. Pharmacol., 19, 270, 1981.
33. Wolf, M. E. and Roth, R. H., Autoreceptor regulation of dopamine synthesis, Ann. NY Acad. Sci., 604, 323, 1990.
34. Arnt, J., Behavioral studies of dopamine receptors: evidence for regional selectivity and multiplicity, in Dopamine Receptors, Creese. I. and Breese, G., Eds., New York: Alan R. Liss, Inc., 1987, 199.
35. Bradbury, A. J., Cannon, J. G., Costall, B., and Naylot, R. J. J., A comparison of dopamine agonist action to inhibit locomotor activity and to induce stereotyped behaviour in mouse, Eur. J. Pharmacol., 105, 33, 1984.
36. Widzowski, D. V. and Cory-Slechta, D. A., Apparent mediation of the stimulus properties of a low dose of quinpirole by dopaminergic autoreceptors, J. Pharmacol. Exp. Ther., 266, 526, 1993.
37. Svensson, K., Johasson, A. M., Magnusson, T., and Carlsson, A., (+)-AJ 76 and (+)-UH232: central stimulants acting as preferential dopamine autoreceptor antagonists, Naunyn-Schmeid Arch. Pharmacol., 334, 234, 1986.
38. Waters, N., Hansson, L., Lofberg, L., and Carlsson, A., Intracerebral infusion of (+)-AJ76 and (+)-UH232: effects on dopamine release and metabolism in vivo, Eur. J. Pharmacol., 251, 181, 1994.
39. Waters, N., Lagerkvist, S., Lofberg, L., Piercey, M., and Carlsson, A., The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232: a microdialysis study, Eur. J. Pharmacol., 242, 151, 1993.
40. Gainetdinov, R. R., Grekhova, T. V., Sotnikova, T. D., and Rayevsky, K. S., Dopamine D2 and D3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats, Eur. J. Pharmacol., 261, 327, 1994.
41. Gifford, A. N. and Johnson, K. M., A pharmacological analysis of (+)-AJ76 and (+)-UH232 at release regulating pre- and postsynaptic dopamine receptors, Eur. J. Pharmacol., 237, 169, 1993.
42. Cote, T. E., Frey, E. A., and Sekura, R. D., Altered activity of the inhibitory guanyl nucleotide-binding component (Ni) induced by pertussis toxin. Uncoupling of Ni from receptor with continued coupling of Ni to the catalytic unit, J. Biol. Chem., 259, 8693, 1984.
43. Elazar, Z., Siegel, G., and Fuchs, S., Association of two pertussis toxin-sensitive G proteins with the D2-dopamine receptor from bovine striatum, EMBO J., 8, 2353, 1989.
44. Senogles, S. E., Benovic, J. L., Amlaiky, N., Unson, C., Milligan, G., Vinitsky, R., Spiegel, A. M., and Caron, M. G., The D2-dopamine receptor of anterior pituitary is functionally associated with a pertussis toxin-sensitive guanine nucleotide binding protein, J. Biol. Chem., 262, 4860, 1987.
45. Gilman, A. G., G proteins and dual control of adenylate cyclase, Cell, 36, 577, 1984.
46. Tang, W. J. and Gilman, A. G., Adenylyl cyclases, Cell, 70, 869, 1992.
47. Taussig, R. and Gilman, A. G., Mammalian membrane-bound adenylyl cyclases, J. Biol. Chem., 270, 1, 1995.
48. Birnbaumer, L., Receptor-to-effector signaling through G proteins: roles for beta gamma dimers as well as alpha subunits, Cell, 71, 1069, 1992.
49. Clapham, D. E. and Neer, E. J., New roles for G-protein beta gamma-dimers in transmembrane signalling, Nature, 365, 403, 1993.
50. Choi, E. J., Xia, Z., Villacres, E. C., and Storm, D. R., The regulatory diversity of the mammalian adenylyl cyclases, Curr. Opin. Cell Biol., 5, 269, 1993.
51. 2+ channel diversity, Annu. Rev. Neurosci., 17, 399, 1994.
52. Liu, Y. F., Jakobs, K. H., Rasenick, M. M., and Albert, P. R., G protein specificity in receptor-effector coupling. Analysis of the roles of Go and Gi2 in GH4C1 pituitary cells, J. Biol. Chem., 269, 13880, 1994.
53. 2+ currents in rat anterior pituitary cells, Neuron, 8, 455, 1992.
54. + current in snail neurons, Neuron, 1, 27, 1988.
55. Vallar, L. and Meldolesi, J., Mechanisms of signal transduction at the dopamine D2 receptor, Trends Pharmacol. Sci., 10, 74, 1989.
56. Clapham, D. E., Calcium signaling, Cell, 80, 259, 1995.
57. Enjalbert, A., Sladeczek, F., Guillon, G., Bertrand, P., Shu, C., Epelbaum, J., Garcia-Sainz, A., Jard, S., Lombard, C., Kordon, C., and Bockaert, J., Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretion, J. Biol. Chem., 261, 4071, 1986.
58. Journot, L., Homburger, V., Pantaloni, C., Priam, M., Bockaert, J., and Enjalbert, A., An islet activating protein-sensitive G protein is involved in dopamine inhibition of angiotensin and thyrotropin-releasing hormone-stimulated inositol phosphate production in anterior pituitary cells, J. Biol. Chem., 262, 15106, 1987.
59. 2+-dependent effect of D2 dopaminergic receptor activation in rat lactotroph cells, J. Biol. Chem., 263, 10127, 1988.
60. Desrues, L., Lamacz, M., Jenks, B. G., Vaudry, H., and Tonon, M. C., Effect of dopamine on adenylate cyclase activity, polyphosphoinositide metabolism and cytosolic calcium concentrations in frog pituitary melanotrophs, J. Endocrinol., 136, 421, 1993.
61. 2+ concentration decrease in GH4C1 cells, J. Biol. Chem., 265, 10320, 1990.
62. Braun, A. P. and Schulman, H., The multifunctional calcium/calmodulin-dependent protein kinase: from form to function, Annu. Rev. Physiol., 57, 417, 1995.
63. + channel is stimulated by three distinct Gi alpha-subunits, Nature, 336, 680, 1988.
64. Van Dongen, A. M., Codina, J., Olate, J., Mattera, R., Joho, R., Birnbaumer, L., and Brown, A. M., Newly identified brain potassium channels gated by the guanine nucleotide binding protein Go, Science, 242, 1433, 1988.
65. Liu, L., Shen, R. Y., Kapatos, G., and Chiodo, L. A., Dopamine neuron membrane physiology: characterization of the transient outward current (IA) and demonstration of a common signal transduction pathway for IA and IK, Synapse, 17, 230, 1994.
66. 2+ increases in rat lactotroph cells. Evidence of a dual mechanism of action, J. Biol. Chem., 262, 13920, 1987.
67. Koch, B. D., Blalock, J. B., and Schonbrunn, A., Characterization of the cyclic AMP-independent actions of somatostatin in GH cells. I. An increase in potassium conductance is responsible for both the hyperpolarization and the decrease in intracellular free calcium produced by somatostatin, J. Biol. Chem., 263, 216, 1988.
68. Drukarch, B., Schepens, E., and Stoof, J. C., Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: indications for a common signal transduction pathway, Neuroscience, 37, 1, 1990.
69. 2+, J. Neurochem., 52, 1680, 1989.
70. Piomelli, D. Pilon, C., Giros, B., Sokoloff, P., Martres, M. P., and Schwartz, J. C., Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism, Nature, 353, 164, 1991.
71. Piomelli, D., Arachidonic acid in cell signaling, Curr. Opin. Cell Biol., 5, 274, 1993.
72. Glaser, K. B., Mobilio, D., Chang, J. Y., and Senko, N., Phospholipase A2 enzymes: regulation and inhibition, Trends Pharmacol. Sci., 14, 92, 1993.
73. Piomelli, D. and Di Marzo, V., Dopamine D2 receptor signalling via the arachidonic acid cascade: modulation by cAMP-dependent protein kinase A and prostaglandin E2, J. Lipid. Mediat., 6, 433, 1993.
74. Piomelli, D. and Greengard, P., Lipoxygenase metabolites of arachidonic acid in neuronal transmembrane signalling, Trends Pharmacol. Sci., 11, 367, 1990.
75. Bertorello, A. M., Hopfield, J. F., Aperia, A., and Greengard, P., Inhibition by dopamine of (Na(+) +K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism, Nature, 347, 386, 1990.
76. + exchange assessed by quantification of extracellular acidification, J. Biol. Chem., 267, 25748, 1992.
77. Ganz, M. B., Pachter, J. A., and Barber, D. L., Multiple receptors coupled to adenylate cyclase regulate Na-H exchange independent of cAMP, J. Biol. Chem., 265, 8989, 1990.
78. Mansour, A., Meng, F., Meador-Woodruff, J. H., Taylor, L. P., Civelli, O., and Akil, H., Site directed mutagenesis of the human dopamine D2 receptor, Eur. J. Pharmacol., 227, 205, 1992.
79. Neve, K. A., Cox, B. A., Henninsen, R. A., Spanoyannis, A., and Neve, R. L., Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase, Mol. Pharmacol., 39, 733, 1991.
80. Cox, B. A., Henningsen, R. A., Spanoyannis, A., Neve, R. L., and Neve, K. A., Contributions of conserved serine residues to the interactions of ligands with dopamine D2 receptors, J. Neurochem., 59, 627, 1992.
81. Williamson, R. A. and Strange, P. G., Evidence for the importance of a carboxyl group in the binding of ligands to the D2 dopamine receptor, J. Neurochem., 55, 1357, 1990.
82. Woodward, R., Daniell, S. J., Strange, P. G., and Naylor, L. H., Structural studies on D2 dopamine receptors: mutation of a histidine residue specifically affects the binding of a subgroup of substituted benzamide drugs, J. Neurochem., 62, 1664, 1994.
83. Presland, J. P. and Strange, P. G., pH dependence of sulpiride binding to D2 dopamine receptors in bovine brain, Biochem. Pharmacol., 41, R9, 1991.
84. D'Souza, U. M. and Strange, P. G., Structural analysis of the D2 dopamine receptor, Biochem. Soc. Trans., 20, 146S, 1992.
85. Ross, E. M., Signal sorting and amplification through G protein-coupled receptors, Neuron, 3, 141, 1989.
86. Kubo, T., Bujo, H., Akiba, I., Nakai, J., Mishina, M., and Numa, S., Location of a region of the muscarinic acetylcholine receptor involved in selective effector coupling, FEBS Lett., 241, 119, 1988.
87. Kobilka, B. K., Kobilka, T. S., Daniel, K., Regan, J. W., Caron, M. G., and Lefkowitz, R. J., Chimeric alpha 2-, beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity, Science, 240, 1310, 1988.
88. Wong, S. K., Parker, E. M., and Ross, E. M., Chimeric muscarinic cholinergic: beta-adrenergic receptors that activate Gs in response to muscarinic agonists, J. Biol. Chem., 265, 6219, 1990.
89. O'Dowd, B. F., Hnatowich, M., Regan, J. W., Leader, W. M., Caron, M. G., and Lefkowitz, R. J., Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling, J. Biol. Chem., 263, 15985, 1988.
90. Kozell, L. B., Machida, C. A., Neve, R. L., and Neve, K. A., Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction, J. Biol. Chem., 269, 30299, 1994.
91. Strader, C. D., Sigal, I. S., and Dixon, R. A., Structural basis of beta-adrenergic receptor function, FASEB J., 3, 1825, 1989.
92. Montmayeur, J.-P. and Borrelli, E., Transcription mediated by a cAMP-responsive promoter element is reduced upon activation of dopamine D2 receptors, Proc. Natl. Acad. Sci. U.S.A., 88, 3135, 1991.
93. Montmayeur, J.-P., Guiramand, J., and Borrelli, E., Preferential coupling between dopamine D2 receptors and G proteins, Mol. Endocrinol., 7, 161, 1993.
94. Guiramand, J., Montmayeur, J.-P., Ceraline, J., Bhatia, M., and Borrelli, E., Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G proteins, J. Biol. Chem., 270, 7354, 1995.
95. Gamier, J., Osguthorpe, D. J., and Robson, B., Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins, J. Mol. Biol., 120, 97, 1978.
96. Strader, C. D., Dixon, R. A., Cheung, A. H., Candelore, M. R., Blake, A. D., and Sigal, I. S., Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity [published erratum appears in J. Biol. Chem., 263, 3050, 1988], J. Biol. Chem., 262, 16439, 1987.
97. Cotecchia, S., Exum, S., Caron, M. G., and Lefkowitz, R. J., Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function, Proc. Natl. Acad. Sci. U.S.A., 87, 2896, 1990.
98. Savarese, T. M. and Fraser, C. M., In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors, Biochem. J., 283 (Pt. 1), 1, 1992.
99. Okamoto, T., Katada, T., Murayama, Y., Ui, M., Ogata, E., and Nishimoto, I., A simple structure encodes G protein-activating function of the IGF-II/ mannose 6-phosphate receptor, Cell, 62, 709, 1990.
100. Okamoto, T. and Nishimoto L, Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure, J. Biol. Chem., 267, 8342, 1992.
101. Sukumar, M. and Higashijima, T., G-protein-bound conformation of mastoparan-X, a receptor-mimetic peptide, J. Biol. Chem., 267, 21421, 1992.
102. Wakamatsu, K., Okada, A., Miyazawa, T., Ohya, M., and Higashijima, T., Membrane-bound conformation of mastoparan-X, a G-protein-activating peptide, Biochemistry, 31, 5654, 1992.
103. Kobilka, B., Adrenergic receptors as models for G protein-coupled receptors, Annu. Rev. Neurosci., 15, 87, 1992.
104. Haga, T., Haga, K., and Kameyama, K., G-protein-coupled receptor kinases, J. Neurochem., 63, 400, 1994.
105. Baik, J.-H., Picetti, R., Saiardi, A., Thiriet, G., Dierich, A., Depaulis, A., Le Meur, M., and Borrelli, E., Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors, Nature, 377, 424, 1995.
106. Adra, C. N., Boer, P. H., and McBurney, M. W., Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter, Gene, 60, 65, 1987.
107. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin, Proc. Natl. Acad. Sci. U.S.A., 89; 8155, 1992.
108. Zurawski, G., Benedik, M., Kamb, B. J., Abrams, J. S., Zurawski, S. M., and Lee, F. D., Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis, Science, 232, 772, 1986.
109. Bannon, M. J., Lee, J. M., Giraud, P., Young, A., Affolter, H. U., and Bonner, T. I., Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons, J. Biol. Chem., 261, 6640, 1986.
110. Civelli, O., Douglass, J., Goldstein, A., and Herbert, E., Sequence and expression of the rat prodynorphin gene, Proc. Natl. Acad. Sci. U.S.A., 82, 4291, 1985.
111. Kaufman, D. L., McGinnis, J. F., Krieger, N. R., and Tobin, A. J., Brain glutamate decarboxylase cloned in lambda gt-11: fusion protein produces gamma-aminobutyric acid, Science, 232, 1138, 1986.
112. Grima, B., Lamouroux, A., Blanot, F., Biguet, N. F., and Mallet, J., Complete coding sequence of rat tyrosine hydroxylase mRNA, Proc. Natl. Acad. Sci. U.S.A., 82, 617, 1985.
113. Young, W. S. III, Bonner, T. I., and Brann, M. R., Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain, Proc. Natl. Acad. Sci. U.S.A.,. 83, 9827, 1986
114. Kita, H. and Kitai, S. T., Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations, Brain Res., 447, 346, 1988.
115. Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J. Jr., and Sibley, D. R., D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons, Science, 250, 1429, 1990.
116. Fuxe, K., Hökfelt, T., and Nilsson, O., Factors involved in the control of the activity of the tuberoinfundibular dopamine neurons during pregnancy and lactation, Neuroendocrinology, 5, 257, 1969.
117. Frohman, L. A., Endocrinology and Metabolism, McGraw-Hill Book Co., New York, 1987, 252.
118. Yen, S. S. C., Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management, W. B. Saunders Co., Philadelphia, 1991, 376.
119. Janssen, P. A. J., Jageneau, A. H., and Schellekens, K. H. L., Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidine)-butyrophenone. Part IV. Influence of haloperidol (R 1625) and chlorpromazine on the behaviour of rats in an unfamiliar 'open-field' situation, Psychopharmacologia, 1, 389, 1960.
120. Pertwee, R. G., The ring test: a quantitative method for assessing the 'cataleptic' effect of cannabis in mice, Br. J. Pharmacol., 46, 753, 1972.
121. Wolffgramm, J., Rommelspacher, H., and Buck, E., Ethanol reduces tolerance, sensitization, and upregulation of D2-receptors after subchronic haloperidol, Pharmacol. Biochem. Behav., 36, 907, 1990.
122. Xu, M., Moratalla, R., Gold, L.H., Hiroi, N., Koob, G. F., Graybiel, A. M., and Tonegawa, S., Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses, Cell, 79, 729, 1994.
123. . Drago, J., Gerfen, C. R., Lachowicz, J. E., Steiner, H., Hollon, T. R., Love, P. E., Ooi, G. T., Grinberg, A., Lee, E. J., Huang, S. P., Bartlett, P. F., Jose, P. A., Sibley, D. R., and Westphal, H., Altered striatal function in a mutant mouse lacking D1A dopamine receptors, Proc. Natl. Acad. Sci. U.S.A., 91, 12564, 1994.
124. Meador-Woodruff, J. H., Mansour, A., Healy, D. J., Kuehn, R., Zhou, Q. Y., Bunzow, J. R., Akil, H., Civelli, O., and Watson, S. J. Jr., Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain, Neuropsychopharmacology, 5, 231, 1991.
125. Mengod, G., Martinez-Mir, M. I., Vilaro, M. T., and Palacios, J. M., Localization of the mRNA for the dopamine D2 receptor in the rat brain by in situ hybridization histochemistry, Proc. Natl. Acad. Sci. U.S.A., 86, 8560, 1989.
126. Najlerahim, A., Barton, A. J., Harrison, P. J., Heffernan, J., and Pearson, R. C., Messenger RNA encoding the D2 dopaminergic receptor detected by in situ hybridization histochemistry in rat brain, FEBS Lett., 255, 335, 1989.
127. Charuchinda, C., Supavilai, P., Karobath, M., and Palacios, J. M., Dopamine D2 receptors in the rat brain: autoradiographic visualization using a high-affinity selective agonist ligand, J. Neurosci., 7, 1352, 1987.
128. Meador-Woodruff, J. H., Mansour, A., Civelli, O., and Watson, S. J., Distribution of D2 dopamine receptor mRNA in the primate brain, Prog. Neuropsychopharmacol. Biol. Psychiatry, 15, 885, 1991.
129. Wamsley, J. K., Gehlert, D. R., Filloux, F. M., and Dawson, T. M., Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain, J. Chem. Neuroanat., 2, 119, 1989.
130. Mansour, A., Meador-Woodruff, J. H., Bunzow, J. R., Civelli, O., Akil, H., and Watson, S. J., Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis, J. Neurosci., 10, 2587, 1990.